3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
20
Active not recruiting
11
Withdrawn
6
Not yet recruiting
4
Terminated
3
Completed
3
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Advanced Renal Cell Carcinoma
1
Interventions
Specimen Handling
32
Magnetic Resonance Spectroscopy
21
Biopsy
20
Cyclophosphamide
16
Nivolumab
10
Paclitaxel
9
Cisplatin
9
Gemcitabine
8
Bevacizumab
8
venetoclax
7
Vincristine
7
Prednisone
7
Doxorubicin
7
Azacitidine
7
pembrolizumab
6
Radiotherapy
6
Radiosurgery
6
Fluorouracil
6
Etoposide
6
Drug Therapy
6
Docetaxel
6
Taxes
5
Rituximab
5
Oxaliplatin
5
Irinotecan
5
Everolimus
5
Capecitabine
5
fludarabine phosphate
4
fludarabine
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Interventional
×
balstilimab
×
Clear all
NCT05928806
2026-02-11
ARCITECT
Hoosier Cancer Research Network
Phase 2
Suspended
120 enrolled